222 related articles for article (PubMed ID: 33998412)
21. Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial.
Rosano G; Ponikowski P; Vitale C; Anker SD; Butler J; Fabien V; Filippatos G; Kirwan BA; Macdougall IC; Metra M; Ruschitzka F; Kumpeson V; Goehring UM; van der Meer P; Jankowska EA;
Cardiovasc Diabetol; 2023 Aug; 22(1):215. PubMed ID: 37592272
[TBL] [Abstract][Full Text] [Related]
22. Anaemia, iron deficiency and heart failure in 2020: facts and numbers.
Chopra VK; Anker SD
ESC Heart Fail; 2020 Oct; 7(5):2007-2011. PubMed ID: 32602663
[TBL] [Abstract][Full Text] [Related]
23. Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure: Why, Who and How?
Sindone A; Doehner W; Manito N; McDonagh T; Cohen-Solal A; Damy T; Núñez J; Pfister O; van der Meer P; Comin-Colet J
J Clin Med; 2022 May; 11(11):. PubMed ID: 35683366
[TBL] [Abstract][Full Text] [Related]
24. Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON): Study design.
Miñana G; Cardells I; Palau P; Llàcer P; Fácila L; Almenar L; López-Lereu MP; Monmeneu JV; Amiguet M; González J; Serrano A; Montagud V; López-Vilella R; Valero E; García-Blas S; Bodí V; de la Espriella-Juan R; Sanchis J; Chorro FJ; Bayés-Genís A; Núñez J;
Clin Cardiol; 2018 Jun; 41(6):729-735. PubMed ID: 29607528
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and Treatment of Iron Deficiency in Heart Failure: OFICSel study by the French Heart Failure Working Group.
Pezel T; Audureau E; Mansourati J; Baudry G; Ben Driss A; Durup F; Fertin M; Godreuil C; Jeanneteau J; Kloeckner M; Koukoui F; Kesri-Tartière L; Laperche T; Roubille F; Cohen-Solal A; Damy T
ESC Heart Fail; 2021 Apr; 8(2):1509-1521. PubMed ID: 33619905
[TBL] [Abstract][Full Text] [Related]
26. Iron substitution in the treatment of chronic heart failure.
Gstrein C; Meyer M; Anabitarte P
Swiss Med Wkly; 2017; 147():w14453. PubMed ID: 28695549
[TBL] [Abstract][Full Text] [Related]
27. Determinants of quality of life of patients with heart failure and iron deficiency treated with ferric carboxymaltose: FAIR-HF sub-analysis.
Gutzwiller FS; Pfeil AM; Comin-Colet J; Ponikowski P; Filippatos G; Mori C; Braunhofer PG; Szucs TD; Schwenkglenks M; Anker SD
Int J Cardiol; 2013 Oct; 168(4):3878-83. PubMed ID: 23870642
[TBL] [Abstract][Full Text] [Related]
28. Is Correction of Iron Deficiency a New Addition to the Treatment of the Heart Failure?
Silverberg DS; Wexler D; Schwartz D
Int J Mol Sci; 2015 Jun; 16(6):14056-74. PubMed ID: 26096008
[TBL] [Abstract][Full Text] [Related]
29. Treatment of Iron Deficiency in Heart Failure.
Shamsi A; Cannata A; Piper S; Bromage DI; McDonagh TA
Curr Cardiol Rep; 2023 Jul; 25(7):649-661. PubMed ID: 37329419
[TBL] [Abstract][Full Text] [Related]
30. Iron deficiency and cardiovascular disease.
Savarese G; von Haehling S; Butler J; Cleland JGF; Ponikowski P; Anker SD
Eur Heart J; 2023 Jan; 44(1):14-27. PubMed ID: 36282723
[TBL] [Abstract][Full Text] [Related]
31. Heart failure in patients with kidney disease and iron deficiency; the role of iron therapy.
Cases Amenós A; Ojeda López R; Portolés Pérez JM;
Nefrologia; 2017; 37(6):587-591. PubMed ID: 28610806
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of Iron Deficiency Correction in Management of Patients With Heart Failure [from the Registry Analysis of Iron Deficiency-Heart Failure (RAID-HF) Registry].
Wienbergen H; Pfister O; Hochadel M; Michel S; Bruder O; Remppis BA; Maeder MT; Strasser R; von Scheidt W; Pauschinger M; Senges J; Hambrecht R;
Am J Cardiol; 2016 Dec; 118(12):1875-1880. PubMed ID: 27756479
[TBL] [Abstract][Full Text] [Related]
33. Parenteral Iron in Heart Failure: An Indian Perspective.
Sathyamurthy I; Swami OC
J Assoc Physicians India; 2022 Feb; 70(2):11-12. PubMed ID: 35436828
[TBL] [Abstract][Full Text] [Related]
34. Long-term effects of iron deficiency in patients with heart failure with or without anemia: the RAID-HF follow-up study.
Wienbergen H; Pfister O; Hochadel M; Fach A; Backhaus T; Bruder O; Remppis BA; Maeder MT; von Scheidt W; Pauschinger M; Senges J; Hambrecht R;
Clin Res Cardiol; 2019 Jan; 108(1):93-100. PubMed ID: 30003365
[TBL] [Abstract][Full Text] [Related]
35. Cost effectiveness of implementing ESC guidelines for treatment of iron deficiency in heart failure in the Nordic countries.
Hofmarcher T; Cabrales Alin D; Linde C
Scand Cardiovasc J; 2018 Dec; 52(6):348-355. PubMed ID: 30457358
[TBL] [Abstract][Full Text] [Related]
36. Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners.
Drozd M; Jankowska EA; Banasiak W; Ponikowski P
Am J Cardiovasc Drugs; 2017 Jun; 17(3):183-201. PubMed ID: 28039585
[TBL] [Abstract][Full Text] [Related]
37. In patients with acute HF and iron deficiency, IV ferric carboxymaltose improved quality of life at 4 to 24 wk.
Donato AA; Green J
Ann Intern Med; 2021 Oct; 174(10):JC110. PubMed ID: 34606316
[TBL] [Abstract][Full Text] [Related]
38. IV Sodium Ferric Gluconate Complex in Patients Hospitalized Due to Acute Decompensated Heart Failure and Iron Deficiency.
Borreda I; Zukermann R; Epstein D; Marcusohn E
J Cardiovasc Pharmacol Ther; 2022; 27():10742484211055639. PubMed ID: 34994220
[No Abstract] [Full Text] [Related]
39. Iron Deficiency: A New Target for Patients With Heart Failure.
Rizzo C; Carbonara R; Ruggieri R; Passantino A; Scrutinio D
Front Cardiovasc Med; 2021; 8():709872. PubMed ID: 34447793
[TBL] [Abstract][Full Text] [Related]
40. Correction of iron deficiency in hospitalized heart failure patients does not improve patient outcomes.
Mistry RH; Kohut A; Ford P
Ann Hematol; 2021 Mar; 100(3):661-666. PubMed ID: 33169197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
